Struggling in that PS5 game? Don't worry, a ghost player who can look like Yoda trained on YouTube, Twitch and social media posts can help you ...

The US Marines abandoned by the Navy in World War II Vice Ganda apologizes to Ion Perez, opens up about dream of becoming a ...

In September 2025, TG Therapeutics presented updated six-year data from the ULTIMATE I & II Phase 3 trials of BRIUMVI® (ublituximab-xiiy) for relapsing multiple sclerosis at the ECTRIMS annual meeting ...

TG Therapeutics recently completed a US$100 million share repurchase program, buying back approximately 3.5 million shares, and the Board of Directors has authorized an additional US$100 million ...

Top 5 tutorials for learning costume design—essential guides to mastering character outfits, fabric rendering, and creative styling for memorable looks! Marjorie Taylor Greene announces resignation ...

TG TET 2025 hall ticket: The Department of School Education Hyderabad will be conducting the TET June 2025 exam from June 15 to 30 this year. On Wednesday, TG TET admit card was released on the ...

A huge miss on the bottom line drove investors away from the shares. Yet sales of the company's one commercialized medicine have been brisk. The company, best known for its multiple sclerosis (MS) ...

Task Group 5/1 is responsible for the development of draft CPM text under WRC-19 Agenda item 1.13.

Japan's Tokyo Gas expands in US shale gas with Chevron deal TG Natural Resources LLC (TGNR), co-owned by Tokyo Gas and Castleton Commodities International, has bought a 70% stake in east Texas gas ...

In the preceding three months, 5 analysts have released ratings for TG Therapeutics (NASDAQ:TGTX), presenting a wide array of perspectives from bullish to bearish. The following table encapsulates ...

Analysts' ratings for TG Therapeutics (NASDAQ:TGTX) over the last quarter vary from bullish to bearish, as provided by 5 analysts. The table below summarizes their recent ratings, showcasing the ...